Ha habido 50 transacciones internas recientes registradas para TFF Pharmaceuticals, Inc. (TFFP), incluyendo 42 compras y 4 ventas. El total de compras internas fue valorado en $823.75K y el total de ventas internas en $684.23K.
Internos destacados con actividad reciente incluyen Rocamboli Stephen, Mills Robert S, King Thomas Braxton. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — TFFP
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-07-03 |
Rocamboli Stephen |
Director |
Concesión de RSU |
3,165 |
$1.82 |
$5.76K |
3,165 |
| 2024-07-03 |
Mills Robert S |
Director |
Concesión de RSU |
3,165 |
$1.82 |
$5.76K |
3,165 |
| 2024-07-03 |
King Thomas Braxton |
Director |
Concesión de RSU |
1,583 |
$1.82 |
$2.88K |
1,583 |
| 2024-07-03 |
Roberts Brandi |
Director |
Concesión de RSU |
3,165 |
$1.82 |
$5.76K |
3,165 |
| 2024-07-03 |
Lee Catherine Chai-zon |
Director |
Concesión de RSU |
1,583 |
$1.82 |
$2.88K |
1,583 |
| 2024-07-03 |
Weisman Harlan F |
President and CEO |
Concesión de RSU |
27,480 |
$1.82 |
$50.01K |
27,480 |
| 2024-07-03 |
Coleman Kirk Allen |
Chief Financial Officer |
Concesión de RSU |
10,184 |
$1.82 |
$18.53K |
10,184 |
| 2024-07-03 |
Mikhak Zamaneh |
Chief Medical Officer |
Concesión de RSU |
10,184 |
$1.82 |
$18.53K |
10,184 |
| 2024-04-18 |
Rocamboli Stephen |
Director |
Concesión de RSU |
4,667 |
- |
- |
4,667 |
| 2024-04-18 |
Mills Robert S |
Director |
Concesión de RSU |
4,667 |
- |
- |
4,667 |
| 2024-04-18 |
King Thomas Braxton |
Director |
Concesión de RSU |
3,110 |
- |
- |
3,110 |
| 2024-04-18 |
Roberts Brandi |
Director |
Concesión de RSU |
5,333 |
- |
- |
5,333 |
| 2024-04-18 |
Lee Catherine Chai-zon |
Director |
Concesión de RSU |
3,556 |
- |
- |
3,556 |
| 2024-04-18 |
Weisman Harlan F |
President and CEO |
Concesión de RSU |
44,967 |
- |
- |
44,967 |
| 2024-04-18 |
Coleman Kirk Allen |
Chief Financial Officer |
Concesión de RSU |
5,300 |
- |
- |
5,300 |
| 2024-04-18 |
Mikhak Zamaneh |
Chief Medical Officer |
Concesión de RSU |
5,300 |
- |
- |
5,300 |
| 2024-04-18 |
Patane Michael A |
Director |
Concesión de RSU |
3,556 |
- |
- |
3,556 |
| 2023-12-13 |
King Thomas Braxton |
Director |
Concesión de RSU |
132,442 |
$0.35 |
$46.35K |
132,442 |
| 2023-12-11 |
King Thomas Braxton |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-12-01 |
Rocamboli Stephen |
Director |
Concesión de RSU |
52,858 |
$0.36 |
$19.03K |
52,858 |
| 2023-12-01 |
Mills Robert S |
Director |
Concesión de RSU |
52,858 |
$0.36 |
$19.03K |
52,858 |
| 2023-12-01 |
Roberts Brandi |
Director |
Concesión de RSU |
52,858 |
$0.36 |
$19.03K |
52,858 |
| 2023-12-01 |
Lee Catherine Chai-zon |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-12-01 |
Lee Catherine Chai-zon |
Director |
Concesión de RSU |
132,442 |
$0.36 |
$47.68K |
132,442 |
| 2023-12-01 |
Patane Michael A |
Director |
Desconocido |
- |
- |
- |
- |
| 2023-12-01 |
Patane Michael A |
Director |
Concesión de RSU |
132,442 |
$0.36 |
$47.68K |
132,442 |
| 2023-08-16 |
Carlson Capital L P |
10 Percent Owner |
Venta Informativa |
1,000 |
$0.39 |
$391.60 |
5,064,000 |
| 2023-08-15 |
Rocamboli Stephen |
Director |
Compra Informativa |
20,000 |
$0.25 |
$5K |
36,000 |
| 2023-08-15 |
Mills Robert S |
Director |
Compra Informativa |
40,000 |
$0.25 |
$10K |
55,980 |
| 2023-08-15 |
Roberts Brandi |
Director |
Compra Informativa |
20,000 |
$0.25 |
$5K |
20,000 |
| 2023-08-15 |
Weisman Harlan F |
President and CEO |
Compra Informativa |
600,000 |
$0.25 |
$150K |
814,615 |
| 2023-08-15 |
Coleman Kirk Allen |
Chief Financial Officer |
Compra Informativa |
20,000 |
$0.25 |
$5K |
35,675 |
| 2023-08-15 |
Mikhak Zamaneh |
Chief Medical Officer |
Compra Informativa |
120,000 |
$0.25 |
$30K |
135,000 |
| 2023-08-15 |
Carlson Capital L P |
10 Percent Owner |
Desconocido |
600,000 |
$1.29 |
$774K |
- |
| 2023-08-15 |
Carlson Capital L P |
10 Percent Owner |
Venta Informativa |
215,000 |
$0.44 |
$94.04K |
5,065,000 |
| 2023-03-22 |
Coleman Kirk Allen |
Chief Financial Officer |
Concesión de RSU |
100,000 |
$0.80 |
$80K |
100,000 |
| 2023-03-10 |
Rocamboli Stephen |
Director |
Compra Informativa |
13,000 |
$0.80 |
$10.43K |
16,000 |
| 2023-03-10 |
Weisman Harlan F |
President and CEO |
Compra Informativa |
150,000 |
$0.88 |
$131.84K |
214,615 |
| 2023-03-10 |
Coleman Kirk Allen |
Chief Financial Officer |
Compra Informativa |
12,000 |
$0.79 |
$9.46K |
15,675 |
| 2023-03-10 |
Mikhak Zamaneh |
Chief Medical Officer |
Compra Informativa |
15,000 |
$0.82 |
$12.3K |
15,000 |
| 2023-01-05 |
Mikhak Zamaneh |
Chief Medical Officer |
Disposición |
430,000 |
$0.97 |
$417.1K |
- |
| 2022-12-29 |
Rocamboli Stephen |
Director |
Concesión de RSU |
33,475 |
- |
- |
33,475 |
| 2022-12-29 |
Mills Robert S |
Director |
Concesión de RSU |
33,475 |
- |
- |
33,475 |
| 2022-12-29 |
Roberts Brandi |
Director |
Concesión de RSU |
20,968 |
- |
- |
20,968 |
| 2022-12-29 |
Fletcher Aaron G.l. |
Director |
Concesión de RSU |
33,475 |
- |
- |
33,475 |
| 2022-12-15 |
Weisman Harlan F |
President and CEO |
Compra Informativa |
50,000 |
$1.06 |
$53K |
64,615 |
| 2022-12-03 |
Weisman Harlan F |
President and CEO |
Concesión de RSU |
1,792,450 |
- |
- |
1,792,450 |
| 2022-11-22 |
Fletcher Aaron G.l. |
Director |
Compra Informativa |
21,735 |
- |
- |
21,735 |
| 2022-09-29 |
Thurman Randy H |
Director |
Venta Informativa |
40,255 |
$4.29 |
$172.69K |
- |
| 2022-05-18 |
Weisman Harlan F |
Director |
Compra Informativa |
2,500 |
$5.12 |
$12.8K |
10,000 |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
